An update on adenomyosis in the adolescent

Current Opinion in Obstetrics and Gynecology

Volumn 22, Issue 5, 2010, Pages 388-392

  Dietrich, Jennifer E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

adenomyosis; adolescent; chronic pelvic pain; dysmenorrheal; endometriosis

Indexed keywords

ANASTROZOLE; DANAZOL; GONADORELIN AGONIST; LETROZOLE; LEUPRORELIN; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADENOMATOUS POLYP; ADENOMYOMA; ADENOMYOSIS; CLINICAL TRIAL; DYSMENORRHEA; ENDOMETRIOSIS; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; AROMATASE INHIBITORS; CONTRACEPTIVES, ORAL, COMBINED; ENDOMETRIOSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 77956429696     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32833cefaf     Document Type: Review

References (33)

1. Frontino G, Bianchi S, Ciappina N, et al. The unicornuate uterus with an occult adenomyotic rudimentary horn. J Minim Invasive Gynecol 2009; 16:622-625.
2. Templeman C. Adolescent endometriosis. Obst Gynecol Clin North Am 2009; 36:177-185.
3. Itam SP, Ayensu-Coker L, Sanchez J, et al. Adenomyosis in the adolescent population: a case report and review of the literature. J Pediatr Adolesc Gynecol 2009; 22:e146-e147.
4. Vitonis AF, Baer HJ, Hankinson SE, et al. A prospective study of body size during childhood and early adulthood and the incidence of endometriosis. Hum Reprod 2010; 25:1325-1334. doi: 10.1093/humrep/deq039.
5. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet 2009; 280:529-538.
6. Winterhager E, Fazleabas A, Hillier S. Endometriosis: science and sense. Mol Hum Reprod 2009; 15:575.
7. Meenakshi M, McCluggage G. Vascular involvement in adenomyosis: report of a large series of a common phenomenon with observations on the pathogenesis of adenomyosis. Int J Gynecol Pathol 2010; 29:117-121.
8. Tesone M, Bilotas M, Baranao RI, Meresman G. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis. Gynecol Obstet Invest 2008; 66 (Suppl 1):10-18.
9. Aghajanova L, Velarde MC, Giudice LC. The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis. Endocrinology 2009; 150:3863-3870.
10. Howard FM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol 2009; 16:540-550.
11. Hou Z, Sun L, Gao L, et al. Cytokine array analysis of peritoneal fluid between women with endometriosis of different stages and those without endometriosis. Biomarkers 2009; 14:604-618.
12. Ferrero S, Venturini PL, Ragni N, et al. Pharmacological treatment of endometriosis: experience with aromatase inhibitors. Drugs 2009; 69: 943-952.
13. Takeuchi H, Kitade M, Kikuchi I, et al. Diagnosis, laparoscopic management, and histopathologic findings of juvenile cystic adenomyoma: a review of nine cases. Fertil Steril 2009. doi: 10.1016/j.fertnstert.2009.05.010. [Epub ahead of print]
14. Ho M, Ratts V, Merritt D. Adenomyotic cyst in an adolescent girl. J Pediatr Adolesc Gynecol 2009; 22:e33-e38.
15. Takeda A, Sakai K, Mitsui T, Nakamura H. Laparoscopic management of juvenile cystic adenomyoma of the uterus: report of two cases and review of the literature. J Min Inv Gynecol 2007; 14:370-374.
16. Tahlan A, Nanda A, Mohan H. Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature. Int J Gynecol Pathol 2006; 25:361-365.
17. Dueholm M, Lundorf E. Transvaginal ultrasound or MRI for diagnosis of adenomyosis. Curr Opin Obstet Gynecol 2007; 19:505-512.
18. Tamai K, Koyama T, Umeoka S, et al. Spectrum of MRI features in adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006; 20:583-602.
19. Choudhary S, Fasih N, Papadatos D, Surabhi VR. Unusual imaging appearance of endometriosis. AJR Am J Roentgenol 2009; 192:1632-1644.
20. Grasso RF, Di Giocoma V, Sedati P, et al. Diagnosis of deep infiltrating endometriosis: accuracy of magnetic resonance imaging and transvaginal 3D ultrasonography. Abdom Imaging 2009. doi: 10.1007/s00261-009-9587-7. [Epub ahead of print]
21. Sanfilippo JS, Wakim NG, Schikler KN, Yussman MA. Endometriosis in association with uterine anomaly. Am J Obstet Gynecol 1986; 154:39-43.
22. Taylor E, Williams C. Surgical treatment of endometriosis: location and patterns of disease at reoperation. Fertil Steril 2010; 93:57-61.
23. Khan KN, Kitajima M, Hiraki K, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Human Reprod. 2009; 25:642-653. doi: 10.1093/humrep/ dep437. [Accessed April 2010]
24. Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev 2004; 3:CD003678.
25. Doyle JO, Missmer SA, Laufer MR. The effect of combined surgical-medical intervention on the progression of endometriosis in an adolescent and young adult population. J Pediatr Adolesc Gynecol 2009; 22:257-263.
26. Bedaiwy MA, Mousa NA, Casper RF. Aromatase inhibitors: potential reproductive implications. J Minim Invasive Gynecol 2009; 16:532-539.
27. Gomes MK, Rosa-e-Silva JC, Garcia SB, et al. Effects of the levonorgestrelreleasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod 2009; 24:2736-2745.
28. Sheng J, Zhang JP, Zhang WY, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 2009; 79:189-193.
29. Cho S, Nam A, Chay D, et al. Clinical effects of the levonorgestrel- releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol 2008; 198:373.e1-373.e7.
30. Gold MA, Johnson LM. Intrauterine devices and adolescents. Curr Opin Obstet Gynecol 2008; 20:464-469.
31. Deans EL, Grimes DA. Intrauterine devices for adolescents: a systematic review. Contraception 2009; 79:418-423.
32. Altinas D, Kokcu A, Tosun M, et al. Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis. J Obstet Gynaecol Res 2008; 34:1014-1019.
33. Schindler AE, Henkel A, Morre C, Oettel M. Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis. Arch Gynecol Obstet 2009. doi: 10.1007/s00404-009-1301-z. [Epub ahead of print]